Michael Poisel is listed as a director on 2 SEC Form D filings by 2 issuers between Sep 2016 and Apr 2018: CARISMA Therapeutics Inc. (Philadelphia, PA — biotechnology — 2018; $52.9M reported sold to 13 investors) and ExcaliVir, Inc. (Doylestown, PA — biotechnology — 2016; $734K reported sold to 1 investors).
What this means 2 separate companies raised money with this person listed as director, over about 2 years. Across those companies the filings report $53.7M sold in total.
Listed alongside Bruce Peacock (1 shared filing), Joe Zack (1 shared filing), Margarita Chavez (1 shared filing) and Steven Kelly (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Michael Poisel and found 4 differences: Offering amount changed between filings; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.